ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
wensellg
|
5.3K |
2.6M |
0 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
wensellg
|
5.3K |
2.6M |
0 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
wensellg
|
5.3K |
2.6M |
0 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
wensellg
|
5.3K |
2.6M |
0 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
wensellg
|
5.3K |
2.6M |
0 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
wensellg
|
5.3K |
2.6M |
1 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
wensellg
|
5.3K |
2.6M |
0 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
wensellg
|
5.3K |
2.6M |
1 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: App 3Ys S Itescu,E Rose,J Swedish,B Burns,J Bell,P Facchina
|
|
wensellg
|
8 |
3.9K |
2 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
8
|
3.9K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: App 3Ys S Itescu,E Rose,J Swedish,B Burns,J Bell,P Facchina
|
|
wensellg
|
8 |
3.9K |
1 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
8
|
3.9K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: App 3Ys S Itescu,E Rose,J Swedish,B Burns,J Bell,P Facchina
|
|
wensellg
|
8 |
3.9K |
4 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
8
|
3.9K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
wensellg
|
17K |
6.7M |
4 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
wensellg
|
17K |
6.7M |
3 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
17K
|
6.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
wensellg
|
17K |
6.7M |
2 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
17K
|
6.7M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Second Quarter Results Presentation
|
|
wensellg
|
117 |
30K |
3 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
117
|
30K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
wensellg
|
17K |
6.7M |
15 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
17K
|
6.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
wensellg
|
17K |
6.7M |
4 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
wensellg
|
17K |
6.7M |
2 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
17K
|
6.7M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
wensellg
|
17K |
6.7M |
7 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
17K
|
6.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
wensellg
|
17K |
6.7M |
1 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial 90-Day Survival Outcomes Presented at ISCT
|
|
wensellg
|
251 |
90K |
18 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
251
|
90K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on Chronic Low Back Pain Program
|
|
wensellg
|
340 |
113K |
18 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
340
|
113K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
wensellg
|
17K |
6.7M |
66 |
16/06/21 |
16/06/21 |
ASX - By Stock
|
17K
|
6.7M
|
66
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
wensellg
|
17K |
6.7M |
7 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
17K
|
6.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
wensellg
|
17K |
6.7M |
4 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19
|
|
wensellg
|
425 |
189K |
3 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
425
|
189K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
wensellg
|
1.1K |
313K |
4 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
313K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Update Webcast
|
|
wensellg
|
49 |
13K |
4 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
49
|
13K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19
|
|
wensellg
|
425 |
189K |
18 |
07/11/20 |
07/11/20 |
ASX - By Stock
|
425
|
189K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
wensellg
|
17K |
6.7M |
7 |
02/06/20 |
02/06/20 |
ASX - By Stock
|
17K
|
6.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
wensellg
|
17K |
6.7M |
13 |
02/06/20 |
02/06/20 |
ASX - By Stock
|
17K
|
6.7M
|
13
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
wensellg
|
23K |
13M |
5 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
wensellg
|
5.3K |
2.6M |
2 |
25/03/20 |
25/03/20 |
ASX - By Stock
|
5.3K
|
2.6M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
wensellg
|
5.3K |
2.6M |
2 |
25/03/20 |
25/03/20 |
ASX - By Stock
|
5.3K
|
2.6M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
wensellg
|
17K |
6.7M |
11 |
25/01/20 |
25/01/20 |
ASX - By Stock
|
17K
|
6.7M
|
11
|
|